반응식
[CH3:1][O:2][C:3](=[O:18])[C@H:4]([CH2:16][SH:17])[NH:5][C:6]([O:8][CH2:9][C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1)=[O:7].[CH3:19][C:20]1[CH2:25][CH2:24][CH:23]([C:26]([CH3:28])=[CH2:27])[CH2:22][CH:21]=1>CCOCC>[CH3:1][O:2][C:3](=[O:18])[C@H:4]([CH2:16][S:17][C:26]([CH:23]1[CH2:24][CH2:25][C:20]([CH3:19])=[CH:21][CH2:22]1)([CH3:28])[CH3:27])[NH:5][C:6]([O:8][CH2:9][C:10]1[CH:15]=[CH:14][CH:13]=[CH:12][CH:11]=1)=[O:7]참가 물질
4
실험 절차
The ether is prepared from N-CBZ-L-cysteine methyl ester and α-limonene in a manner similar to that described in Example 1B. The product can be characterized by NMR spectroscopy.
출처 및 근거
- ORD 기록
- ord-31fa0c532fba4f90b398678e9c54bf38
- 출처 데이터셋
- uspto-grants-1987_01
- 특허 번호
- US04638071
연결된 노트
불러오는 중…